Makarenko, Iuliia
Minoyan, Nanor
Høj, Stine
Jutras-Aswad, Didier
Bruneau, Julie
Funding for this research was provided by:
CRISM (139149)
Santé (54905)
Article History
Received: 16 June 2025
Accepted: 24 October 2025
First Online: 25 November 2025
Declarations
:
: Institutional review board approval was obtained at the Centre Hospitalier de l’Université de Montréal; written informed consent was required. Study interviewers were experienced in administering questionnaires with potentially sensitive subject matter to members of this population.
: The datasets analyzed during the current study are not publicly available due to privacy concerns but are available from the corresponding author on reasonable request.
: IM, NM, SH declare that they have no conflict of interest. DJA received study materials for a clinical trial entirely funded by the Quebec Ministry of Health and Social Services (2022–23), and has salary support from Fonds de recherche du Québec – Santé (FRQS) (unrelated to the current work). JB received honorariums from Gilead Sciences and Abbvie, a research grant from Gilead and holds the Canada Research Chair in Addiction Medicine (unrelated to the current work).